Patients with advanced Alzheimer's disease treated with 13.3 mg rivastigmine patch showed greater improvements in cognitive, functional, and behavioral performance from baseline compared to patients who received 4.6 mg patches.
Ruth J Hickman, MD
Advertisement
Articles by Ruth J Hickman, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Inhaled Treprostinil Improves IPF Outcomes in Phase 3 TETON-1 Trial
2
Moving the Needle in Medicine: Mentorship, Medicine, and the Making of an Innovator, With Jim Januzzi, MD
3
What We Still Don't Know: Gaps, Phototherapy, and the Future of Pediatric Eczema Care
4
When and How to Escalate Pediatric Atopic Dermatitis Treatment
5